| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.77 | 0.3 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.49 | 0.09 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.43 | 0.1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.34 | 0.05 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.3 | 0.07 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.28 | 0.08 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.26 | 0.4 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.2 | 0.5 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.2 | 0.09 |